A French study found that follitropin alfa, a biosimilar fertility drug, is more cost-effective compared with its originator, leading to potential savings for both patients and the health care system.

Generous paid maternity leave, free in-home nurse visits, subsidized child care — sound like a mother's paradise? It's just regular care in... France's Model Health Care For New Mothers Mary Lou ...